Diagnostic and surgical approaches to treating the disease are evolving — just as rates are spiking. Learn how the surgical ...
A new study published in the journal of BMC Surgery showed that in a group of chosen patients with sudden blockage in the ...
In pMMR/MSS colon cancer, neoadjuvant BOT+BAL met the trial’s primary endpoint with a 36% major pathologic response rate, including 29% pathologic complete response, within an overall 71% pathologic ...
UNICORN Challenges Immunotherapy Resistance in MSS Colon Cancer / Agenus, Balstilimab, botensilimab, cancer, Colon cancer, ...
If it might be cancer, please take a sample and clarify it quickly.This is a phrase I often hear from patients and their ...
Hosted on MSN
My tiredness and back pain were dismissed as gallstones - in fact it was a little-known cancer
Tania Sparkes, 40, from Greater Manchester tells her story. My symptoms started in my late twenties, around 2015, when I suddenly became completely exhausted. I just put it down to everyday life, ...
What she thought was the flu turned out to be a medical emergency.
This time, instead of talking about my children's studies, I'm sharing the story of how I (a mom in my late 40s) had my first ...
Basel, 9 October 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and Tecentriq Hybreza® (atezolizumab ...
A new Cell Division study reports that linalool stabilizes the NR3C2 protein in gastric cancer cells, activating NFKBIZ and ...
A retrospective Chinese cohort study of 308 older colorectal cancer patients found that 55.52% carried preoperative frailty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results